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Abstract
Normally, neutrophil pools are maintained by homeostatic mechanisms that require the transcription factor C/EBPa.
Inflammation, however, induces neutrophilia through a distinct pathway of ‘‘emergency’’ granulopoiesis that is dependent
on C/EBPb. Here, we show in mice that alum triggers emergency granulopoiesis through the IL-1RI-dependent induction of
G-CSF. G-CSF/G-CSF-R neutralization impairs proliferative responses of hematopoietic stem and progenitor cells (HSPC) to
alum, but also abrogates the acute mobilization of BM neutrophils, raising the possibility that HSPC responses to
inflammation are an indirect result of the exhaustion of BM neutrophil stores. The induction of neutropenia, via depletion
with Gr-1 mAb or myeloid-specific ablation of Mcl-1, elicits G-CSF via an IL-1RI-independent pathway, stimulating
granulopoietic responses indistinguishable from those induced by adjuvant. Notably, C/EBPb, thought to be necessary for
enhanced generative capacity of BM, is dispensable for increased proliferation of HSPC to alum or neutropenia, but plays a
role in terminal neutrophil differentiation during granulopoietic recovery. We conclude that alum elicits a transient increase
in G-CSF production via IL-1RI for the mobilization of BM neutrophils, but density-dependent feedback sustains G-CSF for
accelerated granulopoiesis.
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Introduction
C/EBPa and -b play critical roles in regulating the tempo of
granulopoiesis. Neutrophil pools in the blood and BM are
normally maintained by a granulopoietic process dependent on
the C/EBPa transcription factor [1,2]. In contrast, inflammation
accelerates granulopoiesis and induces neutrophilia by a distinct
form of granulopoiesis acting through a C/EBPb-dependent
pathway [2,3]. C/EBPb is thought to facilitate proliferation by
myeloid progenitor cells in response to inflammatory growth
factors [2], but the extracellular signals that stimulate neutrophil
production during inflammatory responses are unclear.
Mice with a conditional deletion of C/EBPa fail to produce
neutrophils due to defective generation of granulocyte/macrophage
progenitors (GMP) from common myeloid progenitors (CMP) [4].
Granulopoiesis can be rescued in C/EBPa
2/2 mice by exogenous
GM-CSF or IL-3 [2], or by the expression of C/EBPb from the C/
EBPa locus [5]. C/EBPb
2/2 mice, in contrast, exhibit normal
numbers of neutrophils in the steady-state, but fail to mount
neutrophilias in response to infection or cytokine treatment,
implicating C/EBPb as a regulator of emergency granulopoiesis
[2]. Growth factors elicited during infections are thought to reduce
C/EBPa expression in GMP while increasing C/EBPb expression,
and thereby focusing differentiation towards neutrophils while
elevating rates of proliferation [2]. The model that has emerged
from theseobservations is that C/EBPa and C/EBPb control distinct
pathways of steady-state and emergency granulopoiesis, respectively.
While neutrophilias are commonly associated with inflamma-
tion, it is generally thought that granulopoiesis is a dynamic
process that also responds to non-inflammatory cues elicited
through feedback. Evidence for feedback mechanisms of granu-
lopoiesis was first provided in studies showing that animals
rendered neutropenic via leukapheresis [6], neutrophil anti-serum
[7], or irradiation [8] exhibited expansions of myeloid precursor
populations in BM prior to the recovery of mature neutrophil
compartments. In patients with cyclic neutropenia, the periodic
oscillations in blood neutrophil counts are thought to result from
dysfunctional feedback regulation of granulopoiesis [9]. Numerous
models for granulopoietic regulation have been proposed and most
contain a feedback component that links the population density of
neutrophils to the proliferation and differentiation of neutrophil
precursors [10,11,12,13]. The mechanisms of feedback are still
debated, however, and the roles of C/EBPa and C/EBPb in the
active regulation of granulopoiesis have not been addressed.
Several cytokines can modulate neutrophil production, but G-
CSF is the primary regulator of steady-state and emergency
granulopoiesis (reviewed in [14]). In addition to regulating
neutrophil output, signaling through G-CSF and G-CSF receptor
(G-CSF-R) also controls neutrophil survival, function, and egress
from BM [15,16,17]. Consequently, mice lacking G-CSF or G-
CSF-R are severely neutropenic [15,16]. G-CSF-independent
pathways of granulopoiesis exist, however, as mature neutrophils
are present in both G-CSF
2/2 and G-CSF-R
2/2 mice, albeit in
lower numbers [15,16]. Furthermore, G-CSF is dispensable for the
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31inflammatory neutrophilia elicited by fungal infection [18],
indicative of a compensatory signal(s) that enhances granulopoiesis
in response to pathogens. Candidate factors for the inflammatory
induction of granulopoiesis include GM-CSF, IL-3, and IL-6
[19,20,21,22]. Microbial products may also enhance myelopoiesis
directly, as TLR ligation on HSPC induces proliferation and
myeloid differentiation in vitro [23].
Recently, we demonstrated that the sterile adjuvant alum
induces emergency granulopoiesis by increasing the proliferation
of hematopoietic stem cells (HSC), multipotent progenitors (MPP),
and granulocyte/macrophage progenitors (GMP). In IL-1RI
2/2
mice, alum does not increase the proliferation of HSPC [3].
However, the IL-1RI sensitive compartment in these mice is not
HSPC but a radiation-resistant cell population that is not
transferred by hematopoietic reconstitution [3]. Therefore, IL-
1RI signaling must elicit another factor that activates HSPC for
accelerated neutrophil production.
Here, we show that alum rapidly elicits G-CSF via IL-1RI-
dependent signals. Interference with G-CSF/G-CSF-R abrogated
the inflammatory mobilization of BM neutrophils and increases in
HSPC proliferation, raising the possibility that increased HSPC
proliferation is an indirect effect of reduced BM neutrophil
numbers. Indeed, in vivo depletions of neutrophils stimulated
HSPC proliferation and emergency granulopoiesis as well as alum.
We conclude that inflammation rapidly induces G-CSF for the
mobilization of BM neutrophils, but the resulting BM neutropenia
triggers increases in HSPC proliferation through a density-
dependent feedback mechanism. Notably, the transcription factor
C/EBPb, thought to be necessary for enhancing the generative
capacity of bone marrow, is dispensable for increased proliferation
of HSPC but plays a role in terminal neutrophil differentiation
during granulopoietic recovery from neutropenia. These observa-
tions reveal the BM neutrophil population density as a key
regulator of neutrophil production; inflammation mobilizes BM
neutrophils, effecting neutropenia which, in turn, activates a
density-dependent feedback mechanism for increased HSPC
proliferation and focused neutrophil production.
Materials and Methods
Ethics Statement
All studies were approved by the Duke University Institutional
Animal Care and Use Committee (permit number 240-08-09), and
every effort was taken to minimize animal suffering.
Mice
C57BL/6, congenic IL-1RI
2/2 mice (B6.129S7-Il1r1
tm1Imx/J
[24]), and RAG1
2/2 mice (B6.129S7-Rag1
tm1Mom/J[25]) were
from Jackson Laboratories. Dr. Y. Yang (Duke University)
provided MyD88
2/2 mice [26]. C1q
2/2 mice [27] were obtained
from Dr. M. Walport (Imperial College). C3
2/2 mice [28] and
FcR common c chain deficient mice (FcRc
2/2 [29]) were
provided by Dr. T. F. Tedder (Duke University). LysM
Cre/wt
Mcl-1
f/f and LysM
wt/wt Mcl-1
f/f mice [30] were provided by Dr.
Y. He (Duke University). C/EBPb hemizygous mice on 129/Sv
and BL/6 background strains were provided by Dr. Peter Johnson
(NCI); C/EBPb
2/2 mice and control littermates were generated
by intercrossing hemizygous 129/Sv and BL/6 parents. Bone
marrow cells from CX3CR1
GFP/+ mice [31] were provided by Dr.
M.D. Gunn (Duke University). G-CSF-R
2/2 mice [16] were
provided by Dr. D. Link (Washington University). All mice were
housed in specific pathogen-free conditions at the Duke University
Animal Care Facility with sterile bedding, water, and food;
MyD88
2/2 mice were provided with antibiotic in water.
Purification of Gr-1 mAb
Gr-1 mAb [32] was purified from serum-free supernatants using
a HiTrap Protein G column (GE Healthcare) and dialyzed in
sterile PBS.
Injection of adjuvant and purified proteins
Mice were immunized i.p. with chicken c-globulin (CGG)
conjugated to (4-hydroxy 3-nitrophenyl)acetyl (NP) (NP9-11-CGG)
precipitated in alum [33]. Purified Gr-1 mAb or anti-Ly-6G mAb
(100 mg, clone 1A8, Biolegend) was diluted to 200 ml in PBS and
injected i.p. To neutralize G-CSF in vivo, mice were injected i.v.
with 100 mg anti-mouse GCSF (R&D Systems, clone 67604) 30
minutes before immunization or Gr-1 injection.
Flow Cytometry
FITC-, PE-, PE-Cy5-, APC-, APC-Cy7 or APC-eFluor 780,
PE-Texas Red-, PE-Cy7-, and biotin-conjugated antibodies to Ly-
6G (clone 1A8), Gr-1, CD11b, Ter119, CD4, CD8, B220, TCRb,
Ly-6C, CD31, CD34, c-Kit, Sca-1, FccRII/III, and Flt3 were
from BD Pharmingen or eBioscience. PE-conjugated Ly-6B mAb
was obtained from AbD Serotec and FITC-conjugated anti-CCR3
was obtained from R&D Systems.
Mice were bled via the retro-orbital sinus and blood was
collected in heparin solution. Femurs and tibiae from both legs
were harvested. BM was flushed out with cold IMDM containing
2% FBS. Erythrocytes were lysed in ammonium chloride buffer.
Single-cell suspensions were labeled with combinations of
fluorochrome-antibody conjugates; propidium iodide (Sigma-
Aldrich) identified dead cells.
As injected Gr-1 mAb reduced levels of ex vivo labeling with
fluorochrome-Gr-1 conjugates, Gr-1
+ cells were routinely identi-
fied by the following procedure. In a first round of labeling, cells
were exposed to unconjugated Gr-1, washed, and saturated with
FITC-conjugated anti-rat IgG (Southern Biotech). This method
ensured the identification of all Gr-1
+ cells, whether labeled in vivo
or ex vivo. After washing, labeling with other antibody conjugates
was carried out in a second round of staining.
Antibody-labeled cells were analyzed on a LSRII flow
cytometer (BD Biosciences) or sorted with a FACSVantage (BD
Biosciences). Cell sorting was performed in the Duke Human
Vaccine Institute Research Flow Cytometry Shared Resource
Facility. Flow cytometric data were analyzed with FlowJo software
(Treestar). Cytospins of sorted cells were stained using Hema3
(Fisher Scientific) to confirm their identities (Fig. S1). For analysis
of BrdU uptake by HSPC, HSC were identified as Flt3
2Lin(Gr-1,
CD11b, Ter119, CD4, CD8, B220)
2c-Kit
+Sca-1
+, MPP were
identified as Flt3
+Lin
2c-Kit
+Sca-1
+, and GMP were defined as
Lin
2c-Kit
+Sca-1
2FccRII/III
+ [3].
BrdU labeling
HSPC proliferation was determined using a BrdU labeling kit
(BD Biosciences). Six hours before sacrifice, mice were injected i.p.
with 1 mg BrdU in 200 ml PBS. After labeling with fluorochrome-
antibody conjugates specific for surface antigens, BM cells were
fixed/permeabilized, treated with DNase, and incubated with
FITC anti-BrdU.
Quantification of serum cytokines
Serum cytokines were analyzed in the Duke Human Vaccine
Institute Immune Reconstitution & Biomarker Shared Resource
Facility. Sera were prepared from naı ¨ve BL/6, Mcl-1
+, Mcl-1
2
mice, and BL/6 mice injected with alum or 100 mg Gr-1 mAb.
Cytokine concentrations in undiluted serum samples were
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Readings below the lowest point in the standard curve were
mathematically extrapolated, but these measurements were
imprecise.
Serum G-CSF was quantified by ELISA. Wells of a 96-well
plate were coated overnight with anti-G-CSF (R&D Systems,
clone 67604) then blocked for 1 hour with PBS/1%BSA. Serum
was added to wells and incubated for 2 hours at room
temperature. Bound G-CSF was detected with biotinylated anti-
GCSF (R&D Systems) and SA-horseradish peroxidase (Southern
Biotechnology). Horseradish peroxidase activity was revealed with
a tetramethylbenzadine peroxidase substrate kit (Bio-Rad). G-CSF
concentrations in samples were calculated from a standard curve
of recombinant mouse G-CSF (Peprotech); the sensitivity of the
assay was 10 pg/ml G-CSF.
Statistics
Significance in paired data was determined by Student’s t-test.
Relationships between cell numbers and the frequencies of BrdU
+
HSC, MPP, and GMP were evaluated using the Pearson product
moment correlation coefficient. Hematopoietic responses of C/
EBPb-sufficient and -deficient mice to Gr-1 or alum treatment
were compared using a two-way ANOVA with Tukey post-hoc
test.
Results
Alum induces HSPC proliferation via IL-1RI-dependent
G-CSF induction
Alum elicits reactive neutrophilia by increasing HSC and GMP
proliferation through an IL-1RI-dependent pathway [3]. Since G-
CSF is an important regulator of granulopoiesis [14], we
determined if alum induces G-CSF via IL-1RI by measuring G-
CSF concentrations in the serum of immunized BL/6 and
congenic IL-1RI
2/2 mice. In BL/6 mice, G-CSF concentrations
rose from 70 pg/ml to 2.5 ng/ml at 6 h after immunization, and
remained elevated at 0.7 ng/ml for two days after injection
(Fig. 1A). Although serum G-CSF concentrations were equivalent
in naı ¨ve BL/6 and IL-1RI
2/2 mice, G-CSF production in
response to alum in IL-1RI
2/2 mice was significantly impaired
(Fig. 1A), indicating that alum induces G-CSF via IL-1RI-
dependent signals.
To investigate the role of G-CSF in alum-induced HSC and
GMP proliferation, we administered a G-CSF neutralizing mAb
[34] to BL/6 mice 30 minutes prior to immunization; HSC and
GMP proliferation was measured by BrdU incorporation one day
after immunization [3]. Anti-G-CSF treatment had no effect on
basal HSC and GMP proliferation, but completely abrogated
HSC responses to alum (Fig. 1B). In contrast, anti-G-CSF
treatment only partially blocked the effects of alum on GMP
proliferation (Fig. 1B), suggesting that G-CSF-independent signals
generated during the inflammatory response may specifically
target GMP to increase proliferation. Alternatively, if G-CSF
neutralization is incomplete, GMP may be more sensitive than
HSC to residual G-CSF.
We next examined the effects of alum on HSPC proliferation in
mice lacking G-CSF-R [16]. In naive G-CSF-R
2/2 mice, the
frequencies of BrdU
+ HSC and GMP were identical to congenic
BL/6 controls (Fig. 1C). The number of HSC in BM of G-CSF-
R
2/2 mice was the same as in BL/6 mice (0.660.2610
5 HSC in
G-CSF-R
2/2 mice vs. 0.660.1610
5 cells in BL/6 mice, P.0.05),
but GMP numbers were reduced by 60% (2.160.5610
5 GMP in
G-CSF-R
2/2 mice vs. 5.060.1610
5 cells in BL/6 mice, P#0.01),
consistent with previous reports [15,16]. Although G-CSF-R was
Figure 1. IL-1RI-dependent induction of G-CSF is critical for BM
neutrophil mobilization and increased HSPC proliferation after
alum immunization. (A) Serum G-CSF concentrations in BL/6 (closed)
and IL-1RI
2/2 (open) mice after alum immunization. The mean(+SD) of
serum G-CSF concentration is shown; statistical differences between G-
CSF concentrations in BL/6 and IL-1RI
2/2 mice at each interval are
indicated (n=3–7). (B) Effects of G-CSF neutralization on alum-induced
HSC and GMP proliferation. BL/6 mice were treated or not with anti-G-
CSF mAb, then immunized or not with alum; mice were sacrificed
24 hours later for analysis. Six hours prior to sacrifice, mice were injected
i.p. with BrdU; the mean frequencies(+SD) of BrdU
+ cells in the HSC and
GMP compartments are shown (n=4–5). (C) Alum immunization of G-
CSF-R
2/2 mice. BL/6 and G-CSF-R
2/2 mice were immunized with alum
(grey) or left untreated (open), and then analyzed for BrdU uptake in HSC
and GMP compartments 24 hours later (n=3–9). (D) Effects of G-CSF
neutralization on BM neutrophil mobilization after alum immunization.
BM neutrophils were enumerated 24 hours after immunization (Fig. S1
defines neutrophil populations). The mean numbers(+SD) of mature
neutrophils in the leg bones are shown for each treatment (n=4–5). (E)
BL/6 or G-CSF-R
2/2 mice were immunized with alum (grey) or left
untreated (open), and the number of BM neutrophils was determined
24 hours later (n=3–9). *, P#0.05; **, P#0.01; n.s., not significant.
doi:10.1371/journal.pone.0019957.g001
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not increase BrdU uptake by HSC or GMP in G-CSF-R
2/2 mice
(Fig. 1C), indicating that G-CSF-R is necessary for the
proliferative responses of HSC and GMP to adjuvant.
G-CSF has well-documented growth factor properties, but it is
also a potent mobilizer of BM neutrophils [15,35]. Indeed, anti-G-
CSF treatment significantly impaired neutrophil mobilization by
alum (Fig. 1D) and in G-CSF-R
2/2 mice, alum had no mobilizing
effect on residual BM neutrophils (Fig. 1E) (Fig. S1 defines
leukocyte populations). Thus, G-CSF/G-CSF-R blockade impairs
two components of the inflammatory response that directly
contribute to reactive neutrophilia: mobilization of BM neutro-
phils and increased HSPC proliferation.
Bone marrow neutropenia by antibody depletion
It is now believed that infections accelerate granulopoiesis
through a transcriptional pathway that is distinct from the
processes that maintain neutrophil pools in the steady-state, but
depends on the inflammatory induction of growth factors [2].
However, emergency granulopoiesis might be an indirect effect of
BM neutropenia, as defects in alum-induced HSPC proliferation
coincided with failed neutrophil mobilization (Fig. 1 and Ref. 3).
Indeed, it has been postulated that the consumption of neutrophil
stores during infection might activate feedback mechanisms of
neutrophil replenishment [36]. To test the hypothesis that
reductions in BM neutrophil numbers trigger emergency granu-
lopoiesis, we studied two experimental models for induced
neutropenia that minimize or eliminate ancillary inflammation.
The Gr-1 mAb is used routinely in vivo to deplete neutrophils
[37,38]. We injected BL/6 mice i.p. with 10- or 100 mg of Gr-
1 mAb and compared the loss and recovery of mature neutrophils
in blood and BM to that induced by alum [3]. Whereas alum
elicited a multiphasic neutrophilia in blood, both doses of Gr-1
induced transient neutropenias (.90% reductions; P#0.01) for 2
to 4 days (10- or 100 mg Gr-1, respectively) with recovery on days
6 or 8 (10- or 100 mg Gr-1, respectively) (Fig. 2A). The effects of
Gr-1 mAb were specific, as injection of 100 mg rat IgG had no
effect on blood or BM leukocyte numbers (unpublished data).
Although alum stimulated neutrophilia and Gr-1 effected
neutropenia (Fig. 2A), the two treatments induced similar changes
in BM neutrophil populations. Injection of either alum or Gr-
1 mAb significantly reduced BM neutrophil numbers for two days
(P#0.01, Fig. 2B); afterwards, BM neutrophil numbers recovered
and eventually surged above normal levels on days 6–8 (P#0.01,
all) before gradually returning to normal (Fig. 2B). Notably, the
magnitude of the BM neutrophil ‘‘rebound’’ following Gr-1
treatment outpaced that of alum (Fig. 2B), demonstrating that the
myeloablative effects of passive Gr-1 mAb are sufficient to induce
emergency granulopoiesis.
Given that alum increases proliferation by HSC, MPP, and
GMP [3], we determined whether Gr-1 treatment also increased
HSPC proliferation. The frequencies of BrdU
+ HSC, MPP, and
GMP increased significantly within one day of Gr-1 administra-
tion (P#0.01, all) and then gradually returned to naı ¨ve levels by
days 4–6 (Fig. 2C-E). The transient increases in the frequency of
BrdU
+ HSC, MPP, and GMP were mirrored in the cell numbers
within each progenitor compartment; cell numbers were elevated
when frequencies of BrdU
+ cells were high, and then gradually to
returned to naı ¨ve levels (Fig. S2). This observation is consistent
with a recent report describing an expansion of hematopoietic
progenitor compartments following Gr-1 administration [39].
Notably, administration of 10 mg Gr-1 induced similar prolifera-
tive responses in HSPC compartments as alum and BM neutrophil
numbers peaked simultaneously (day 6; Fig. 2B). Injection of
100 mg Gr-1 resulted in a longer period of elevated HSC
proliferation (Fig. 2C) that was associated with an even greater
rebound in BM neutrophil numbers on day 8 (Fig. 2B). Thus, Gr-1
depletion elicits a granulopoietic response that closely mimics that
induced by alum, consistent with the possibility that a reduction in
BM neutrophil numbers is itself, sufficient to elicit increased HSPC
proliferation and accelerated neutrophil production.
Notably, alum elicited a BM eosinophilia in addition to
neutrophilia whereas Gr-1 had little effect on BM eosinophil
numbers (Fig. S3); inflammation, therefore, more broadly affects
hematopoiesis.
Although Gr-1 mAb depleted neutrophils, other hematopoietic
lineages were also affected, including Gr-1
- B-lineage and
erythroid cells (Fig. S3). While we cannot exclude non-specific
antibody effects, we suspect that reductions in these cell
compartments are secondary to the loss of Gr-1
+ cells.
Bone marrow neutropenia by genetic deletion
We also examined a genetic model of neutropenia for evidence
of increased HSPC proliferation. Mice with the myeloid-specific
deletion of the anti-apoptotic factor Mcl-1 (LysM
Cre/wt Mcl-1
f/f
mice; hereafter Mcl-1
2 mice) exhibit a highly specific defect in
neutrophil survival [30]. Whereas neutrophil numbers in the blood
and BM of Mcl-1
2 mice were only 10% and 20%, respectively, of
control littermates (P#0.01; Fig. 2A, B), the number of developing
neutrophils (Fig. S1) was 2-fold greater in Mcl-1
2 mice (P#0.05;
Table S1). Eosinophil, monocyte, erythroid and B-lineage cell
numbers were normal or slightly elevated (Table S1).
Mature neutrophils in Mcl-1
2/2 mice are lost by a presumably
non-inflammatory, apoptotic mechanism [30,40]. However, HSC,
MPP, and GMP proliferation was constitutively increased in
neutropenic Mcl-1
2 mice compared with littermate controls
(P#0.01, all) (Figs. 2C-E) and the numbers of cells in each HSPC
compartment were significantly elevated (P#0.01, HSC and
GMP; P#0.05, MPP)(Fig. S2), consistent with the hypothesis that
neutropenia is sufficient to stimulate HSPC proliferation and
accelerate neutrophil production.
Induced proliferation of HSPC is inversely proportional to
BM neutrophil numbers
The reciprocal association between BM neutrophil numbers and
HSPC proliferation in BL/6 mice after alum or Gr-1 mAb
injection, and in naı ¨ve Mcl-1
2 mice (Fig. 2A–E) suggested that
the mature neutrophil compartment might directly regulate the
proliferation rates of hematopoietic progenitor cells. During the loss
and recovery of BM neutrophils following injection of Gr-1 mAb or
alum, we observed strong inverse correlations between the numbers
of BM neutrophils and the frequencies of BrdU
+ HSC (R=20.84
to 20.94, P#0.01, Fig. 2F), MPP (R=20.78 to 20.94, P#0.05),
and GMP (R=20.88 to 20.93, P#0.01). Remarkably, an inverse
relationship between BM neutrophil numbers and HSPC prolifer-
ation rates was evident not only when BM neutrophil numbers were
low (days 1–2 after Gr-1 or alum, Fig. 2F) but also when BM
neutrophil numbers climbed above steady-state levels (day 6, 10 mg
Gr-1; days 8–12, 100 mg Gr-1; Fig. 2F). These findings are
consistent with the activity of a feedback system that couples HSPC
proliferation to the population density of BM neutrophils.
If BM neutrophils regulate HSPC proliferation through
feedback, then changes in BM neutrophil numbers should elicit
reciprocal and proportional changes in proliferation rates. We
therefore injected mice with graded doses of Gr-1 mAb (0.1–
100 mg) and observed dose-dependent decreases in BM neutrophil
numbers on day 2, the nadir of neutrophil losses (Fig. 2G). In these
mice, increased frequencies of BrdU
+ HSC (Fig. 2G) were highly
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depletion. Together, these findings implicate the BM neutrophil
population as an important control element in the regulation of
granulopoiesis; changes in the numbers of BM neutrophils alone
are sufficient to alter HSPC proliferation.
Emergency granulopoiesis in the absence of
inflammation
As noted, it is not easy to disentangle the effects of inflammation
(IL-1, G-CSF, etc.) on granulopoiesis from those of neutrophil
depletion (Fig. 2). If neutrophil depletion by Gr-1 mAb elicits
significant inflammation, perhaps through complement fixation or
Fc receptor signaling, then increased HSPC proliferation might
not be due to reduced BM neutrophil numbers.
However, mice deficient for C1q [27] or C3 [28] exhibited
increased HSC proliferation and neutrophil production after Gr-1
administration that were similar to congenic BL/6 mice (Fig. 3A).
In FcRc
2/2 mice [29], the neutrophil depleting capacity of Gr-
1 mAb was diminished, yet the lower reductions in BM neutrophil
numbers remained associated with significant increases in HSC
Figure 2. Adjuvant inflammation and experimental neutropenia elicit similar changes in granulopoiesis. BL/6 mice were i.p. injected
with Gr-1 mAb [10 mg (open squares), 100 mg (closed diamonds)] or alum (shaded triangles), and then blood and BM neutrophils were enumerated at
various intervals. Neutrophils numbers were also determined in Mcl-1
- mice and control littermates. The mean(+SD) numbers of neutrophils/ml of
blood (A) and in the four leg bones (B) after each treatment are shown. In the right panel, the numbers of blood and BM neutrophils in Mcl-1
+ and
Mcl-1
2 mice are indicated. Proliferation of HSC (C), MPP (D), and GMP (E) at intervals after alum or Gr-1 treatment, and in Mcl-1
+ and Mcl-1
2 mice, was
determined by BrdU incorporation. Mice were injected with BrdU 6 hours prior to sacrifice, and the mean frequency(+SD) of BrdU
+ cells in each
compartment is shown (day 0, n=19; for other intervals, n=3–10). (F) BM neutrophil numbers (closed diamonds) and frequencies of BrdU
+ HSC (open
squares) after injection of Gr-1 or alum (as shown in B and C) are co-plotted; the values at each interval represent the fold change from naı ¨ve mice,
expressed as log2. Pearson product moment correlation coefficients (R) between BM neutrophil numbers and the frequencies of BrdU
+ HSC for each
treatment are shown. (G) BL/6 mice were injected with graded amounts of Gr-1 mAb (0, 0.1, 1, 10, and 100 mg; n=4–7 mice per treatment) and then
BM neutrophil numbers and HSC proliferation were determined two days later. Significant differences from naı ¨ve BL/6 mice are shown for neutrophil
numbers (**, P#0.01) and frequency of BrdU
+ HSC (
{{,P #0.01); the Pearson product moment correlation coefficient (R) for BM neutrophil numbers
and frequencies of BrdU
+ HSC is shown.
doi:10.1371/journal.pone.0019957.g002
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numbers (day 8, P#0.05) (Fig. 3A). Granulopoietic responses to
Gr-1 treatment, therefore, are independent of complement or
FcR-dependent events.
IL-1RI expression by radiation resistant cells is necessary for
alum-induced emergency granulopoiesis [3]. To determine if
granulopoietic responses to neutrophil depletion also depend on
IL-1RI signaling, we administered Gr-1 mAb to IL-1RI
2/2 mice;
as expected [3], granulopoietic responses to alum were severely
impaired in IL-1RI
2/2 mice (Fig. 3B) but Gr-1 treatment elicited
increases in HSC proliferation (day 1, P#0.01) and BM neutrophil
numbers (day 8, P#0.01) that were identical to congenic BL/6
mice (Fig. 3B). Similarly, mice lacking MyD88, a crucial signaling
component of many TLR [41] and the IL-1, IL-18 [26], and IL-33
receptors [42], did not activate emergency granulopoiesis in
response to alum, but responded with increased HSC proliferation
(day 1; P#0.01) and granulopoietic output (day 8; P#0.05)
following treatment with Gr-1 mAb (Fig. 3B).
T cells have been implicated as positive regulators of granulo-
poiesis through the production of IL-17 [43]. However, RAG1
2/2
mice, which lack both T and B-lymphocytes [25], had normal
numbers of developing and mature neutrophils in BM (Table S1),
and the frequencies of BrdU
+ HSC, MPP, and GMP were identical
to congenic BL/6 controls (Fig. 3B, unpublished data; P.0.05).
Furthermore, granulopoietic responses in RAG1
2/2 mice to both
alumandGr-1 wereidenticaltoBL/6 mice(Fig.3B),indicating that
signals from T or B lymphocytes are dispensable for HSPC
responses to these treatments.
Our survey (Fig. 3A, B) of inflammatory defects provided no
evidence that passive Gr-1 mAb triggers HSPC proliferation via
intermediate, inflammatory pathways. Notably, HSC proliferation
increased only when BM neutrophil numbers decreased, whether
by mobilization in response to alum or depletion by Gr-1 mAb
(Fig. 3B). We conclude that inflammation targets BM neutrophils
for mobilization, but that emergency granulopoiesis is independent
of IL-1RI, MyD88, or lymphocyte-derived signals.
Neutrophils express the highest amount of Gr-1 surface antigen
of cells in the BM and blood (Fig. S1) but, as previously reported
[44], treatment of mice with Gr-1 mAb depleted Ly-6G
-Ly-6C
+
monocytes (Fig. S3) in addition to neutrophils. Losses of
monocytes, and not neutrophils, might account for increased
HSPC proliferation after Gr-1 injection. However, mice treated
with a Ly-6G-specific mAb [44] exhibited changes in hematopoi-
esis that were similar to those in mice treated in parallel with Gr-
1 mAb: anti-Ly-6G treatment significantly reduced BM neutrophil
numbers (day 1, P#0.01) and increased frequencies of BrdU
+
HSC (day 1, P#0.01)(Fig. 3C). We conclude that the changes in
hematopoiesis following Gr-1 administration are primarily due to
the depletion of neutrophils.
Cytokines, growth factors, and chemokines elicited by
inflammation or neutropenia
Several growth factors have been implicated in emergency
granulopoiesis, including G-CSF, GM-CSF, IL-3, and IL-6. We
determined the concentrations of these factors and 19 other
cytokines, growth factors, and chemokines (Fig. S4) in the sera of
naı ¨ve Mcl-1
+, Mcl-1
2, and BL/6 mice, and in BL/6 animals
injected with alum or Gr-1 mAb (6 h and 1-, 2-, and 8 days after
treatment). The inclusion of naı ¨ve Mcl-1
2 mice and their Mcl-1
+
littermate controls allowed us to distinguish patterns of cytokine
changes elicited by inflammation from those that are solely the
consequence of neutropenia.
Of the 23 factors surveyed, the levels of 15, IL-1a/b, IL-2, IL-3,
IL-4, IL-10, IL-12 p40/p70, IL-13, IL-17,GM-CSF, MIP-1a/b,
RANTES, and TNFa, were identical in naı ¨ve Mcl-1
+, Mcl-1
2,
and BL/6 mice and remained unchanged in BL/6 mice in
response to alum or Gr-1 mAb (Fig. S4). The serum concentra-
tions of three cytokines, IL-9, eotaxin, and IFNc, fell in response to
alum or Gr-1; IL-9, eotaxin, and IFNc levels in naı ¨ve Mcl-1
+ and
Mcl-1
2 mice were also low and not significantly different (Fig. S4).
Alum increased serum IL-5, IL-6, KC, MCP-1 (Fig. S4), and G-
CSF (Fig. 4A); the serum levels of these cytokines peaked at 6 h
after injection and then returned to normal (Fig. S4). Gr-1
administration elicited only KC, MCP-1 (Fig. S4), and G-CSF
(Fig. 4A). In contrast to the rapid rise in serum G-CSF elicited by
alum, there was no increase in G-CSF 6 h after Gr-1 injection
(Fig. 4A) but G-CSF levels gradually increased to those observed in
alum-treated mice on days 1 and 2 before returning to control
levels on day 8 (Fig. 4A). In neutropenic Mcl-1
2 mice, G-CSF
(Fig. 4A) and KC (Fig. S4) were also constitutively elevated
compared to control littermates.
The modest and delayed increases in G-CSF observed after Gr-
1 injection and the constitutive G-CSF in naive Mcl-1
2 mice
might represent a direct consequence of neutropenia
(Fig. 4A).Whereas alum did not elicit G-CSF in the absence of
IL-1RI signals (Fig. 1A), Gr-1 depletion elicited G-CSF equally in
BL/6 and IL-1RI
2/2 mice (Fig. 4B), indicating that G-CSF can
be induced through two distinct pathways: an IL-1RI-dependent
inflammatory pathway and an IL-1RI-independent pathway
activated by neutropenia. We conclude that IL-1RI signals rapidly
induce G-CSF and BM neutrophil mobilization, but that G-CSF
levels are sustained as a result of BM neutropenia.
Neutropenia elicits G-CSF dependent and independent
increases in HSPC proliferation
G-CSF’s capacity to modulate BM neutrophil numbers by
controlling their migration raised the possibility that G-CSF’s effects
on HSPC proliferation might be indirect. To determine if G-CSF/
G-CSF-R signals are required for proliferative HSPC responses to
neutropenia, we injected mice with G-CSF neutralizing mAb then
administered Gr-1 mAb. With G-CSF neutralization, the effects of
Gr-1 depletion on HSC and GMP proliferation were reduced, but
the frequencies of BrdU
+ HSC and GMP were still increased over
naı ¨ve controls (P#0.05, Fig. 4C), indicating that a portion of the
HSPC response to BM neutropenia is G-CSF-dependent.
We next examined the effects of Gr-1 depletion on G-CSF-R
2/2
mice. Gr-1 mAb depleted the residual BM neutrophils in G-CSF-
R
2/2 mice but failed to elicit an increase in GMP proliferation
(Fig. 4D). However, the frequency of BrdU
+ HSC rose modestly but
significantly after Gr-1 injection, indicating that neutropenia
activates a G-CSF-R-independent mechanism for increased HSC
proliferation (Fig. 4D).
C/EBPb is dispensable for increased HSPC proliferation
during emergency granulopoiesis
C/EBPb is thought to be necessary for a distinct pathway of
granulopoiesis elicited by inflammatory signals [2]. However, we
observed that neutropenia increased HSPC proliferation and
neutrophil production similar to alum, but without evidence of
inflammation (Fig. 2 and 3). To determine if C/EBPb is necessary
for granulopoietic responses to neutropenia, we depleted neutro-
phils in C/EBPb
2/2 mice and C/EBPb-sufficient littermates with
Gr-1 mAb. Hematopoiesis in C/EBPb
+/+ and C/EBPb
+/2 mice
was identical; data from these mice were pooled and are referred
to hereafter as C/EBPb
+ mice.
C/EBPb
2/2 mice had equivalent numbers of BM neutrophils
as C/EBPb
+ mice (Fig. 5A), consistent with previous reports [45],
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However, the supranormal recovery of BM neutrophils was
blunted in mice lacking C/EBPb (Fig. 5A); BM neutrophil
numbers peaked on day 6 only modestly higher than in untreated
mice (1.7-fold, P#0.05), and were only half of that in C/EBPb
+
mice at the same interval (P#0.01) (Fig. 5A). Thus, C/EBPb is
required for optimal granulopoietic responses to neutropenia.
C/EBPb is thought to allow for increased proliferation of GMP
in response to growth factors [2] but, surprisingly, C/EBPb
2/2
mice exhibited similar increases in frequencies of BrdU
+ HSC,
MPP, and GMP as C/EBPb
+ mice (Fig. 5A). Although ANOVA
indicated significant differences in the proliferative responses of
HSC and GMP, but not MPP, in C/EBPb
+ and C/EBPb
2/2
mice (P#0.05), a Tukey post-hoc test failed to reveal statistical
Figure 3. Neutrophil depletion with Gr-1 mAb elicits emergency granulopoiesis with minimal inflammation. (A) BL/6 and congenic
C3
2/2, C1q
2/2, and FcRc
2/2 mice were treated with 100 mg G-1 mAb; the mean numbers(+SD) of BM neutrophils (closed) and frequencies(+SD) of
BrdU
+ HSC (open) at days 1 and 8 after treatment are shown. (B) BL/6 mice and congenic IL-1RI
2/2, MyD88
2/2, and RAG1
2/2 mice were injected with
alum or 100 mg Gr-1 mAb; the mean numbers(+SD) of BM neutrophils (closed) and mean frequencies(+SD) of BrdU
+ HSC (open) at days 1 and 8 after
treatment are shown. (n=19 BL/6 mice, day 0; n=3–8 mice for all other data points). (C) BL/6 mice were treated with 100 mg Gr-1 mAb or 100 mg Ly-
6G-specific mAb (clone 1A8); the mean numbers(+SD) of BM neutrophils (closed diamonds for Gr-1 treatment, closed squares for anti-Ly-6G
treatment) and frequencies(+SD) of BrdU
+ HSC (open diamonds for Gr-1 treatment, open squares for anti-Ly-6G treatment) at days 1 and 8 after
antibody injection are shown. (n=3–5 mice for days 0 and 1, n=2 for both treatments at day 8).
doi:10.1371/journal.pone.0019957.g003
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Notably, the frequencies of BrdU
+ HSC and GMP were slightly
higher in C/EBPb
2/2 mice than in C/EBPb
+ mice at day 4 after
Gr-1 treatment (Fig. 5A), although we are uncertain of the
biological relevance of this modest, non-significant increase. We
found no evidence that C/EBPb deficiency restricts the prolifer-
ative capacity of HSC, MPP, or GMP.
The immature neutrophil population, comprising myelocytes
and metamyelocytes (SSC
intLy-6B
intGr-1
intCD11b
+, Fig. S1),
underwent identical changes in C/EBPb
+ and C/EBPb
2/2 mice
after Gr-1 treatment (Fig. 5A), indicating equivalent expansions of
progenitor compartments and cellular delivery into the neutrophil
lineage. These observations dissociate C/EBPb from the prolifer-
ative effects of growth factors on HSPC; instead, the lack of
rebounding neutrophilias in C/EBPb
2/2 mice stems from a
defect at the transition between immature and mature neutrophils.
Interestingly, C/EBPb was dispensable for granulopoietic
responses to alum. Alum elicited similar increases in HSPC
proliferation in C/EBPb
+ and C/EBPb
2/2 mice (Fig. 5B). The
number of mature neutrophils in BM of C/EBPb
2/2 mice on day
6, although modestly lower, was not significantly different from
control mice (Fig. 5B). Since Gr-1 administration elicits a more
robust granulopoietic response than alum (Fig. 2B), C/EBPb-
independent pathways of neutrophil differentiation must suffice for
the replenishment of mature neutrophils after immunization.
Discussion
Microbial infection and/or tissue damage elicit growth factors
that can accelerate granulopoiesis to expedite the elimination of
pathogens and necrotic cells [46]. Recent studies have suggested
that ‘‘emergency’’ or ‘‘demand-driven’’ granulopoiesis represents a
developmental pathway distinct from the steady-state hematopoi-
esis that normally sustains neutrophil pools [2]. Our findings,
however, indicate that the depletion of neutrophil reserves during
acute inflammation activates a feedback mechanism that increases
G-CSF production/availability and accelerates neutrophil pro-
duction. We propose that feedback mechanisms that maintain
neutrophil pools in the steady-state also play critical roles in the
accelerated granulopoiesis associated with inflammation.
We have shown that alum induces emergency granulopoiesis via
IL-1RI-dependent signals [3]. Notably, defective emergency
granulopoiesis in IL-1RI
2/2 mice was accompanied by failed
mobilization of BM neutrophils [3]. Now we demonstrate that
alum triggers IL-1RI-dependent activation of G-CSF (Fig. 1A),
and that G-CSF/G-CSF-R signals are necessary for both the
proliferative responses of HSPC and the mobilization of BM
neutrophils (Fig. 1B-E).
That HSPC proliferation and neutrophil mobilization are
tightly linked in IL-1RI- and G-CSF-R deficient mice suggested
that changes in HSPC proliferation and granulopoiesis in response
to inflammation might reflect the common reduction in BM
neutrophil reserves. Evidence consistent with this sort of feedback
control have been offered previously [6,7,8], and most mathe-
matical models for granulopoietic regulation contain feedback
components linking neutrophil population density to proliferation
and differentiation by neutrophil precursors [10,11,12,13]. Recent
studies have suggested that IL-17-producing T cells modulate G-
CSF production as part of a feedback mechanism that regulates
granulopoiesis [47]. In our hands, however, the BM of RAG1
2/2
and control mice contained equivalent numbers of neutrophils
(Table S1) and RAG1
2/2 mice exhibited normal granulopoietic
responses to alum or passive Gr-1 antibody (Fig. 3B). Studies of
RAG1
2/2 mice do not rule out lymphoid-tissue inducer cells or
double negative 1 T cells as sources of IL-17 for granulopoietic
regulation [48,49], but mature T cells are unnecessary for steady-
state and inflammatory control of BM neutrophil numbers. We
Figure 4. Neutrophil depletion elicits G-CSF-dependent and
-independent HSPC proliferation. (A) Serum from naı ¨ve BL/6, Mcl-
1
+ (closed circle), Mcl-1
2 (open circle) mice, and BL/6 mice treated with
alum (open triangles) or Gr-1 mAb (closed diamonds) was analyzed for
G-CSF in a multiplex bead array. The mean concentrations(+SD) of G-
CSF/ml of serum are shown (n=3–7). (B) Serum G-CSF in BL/6 (closed)
and IL-1RI
2/2 (open) mice after Gr-1 administration; the mean
concentrations(+SD) of G-CSF/ml are shown (n=3–5). (C) Effect of G-
CSF neutralization on proliferative response of HSPC to induced
neutropenia. BL/6 mice were injected or not with anti-GCSF, then
administered Gr-1 mAb. The mean frequencies(+SD) of BrdU
+ cells in
the HSC and GMP compartments, and the numbers(+SD) of BM
neutrophils on day 1 after treatment are shown (n=4–5). (D) BL/6 and
G-CSF-R
2/2 mice were treated or not with Gr-1 mAb, then sacrificed
24 hours later for analysis. The mean frequencies(+SD) of BrdU
+ cells in
the HSC and GMP compartments, and the mean numbers(+SD) of BM
neutrophils are shown (n=3–9). *, P#0.05; **, P#0.01.
doi:10.1371/journal.pone.0019957.g004
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antibody were not different from naı ¨ve controls, Mcl-1
2, or Mcl-
1
+ mice (Fig. S4).
To determine the contribution of feedback to emergency
granulopoiesis, we compared the effects of neutropenia to those
elicited by inflammation by tracking simultaneously HSPC
proliferation and neutrophil production. BM neutropenia was
invariably coupled to increased HSPC proliferation, regardless of
how neutrophil numbers were reduced (Fig. 2). Neutrophil
depletion with Gr-1 mAb induced rapid increases in HSC,
MPP, and GMP proliferation followed by supranormal BM
neutrophil numbers (Fig. 2); mice rendered chronically neutrope-
Figure 5. C/EBPb is dispensable for proliferative responses of HSPC to Gr-1 administration or alum immunization. C/EBPb
2/2 mice
(open) and control littermates (closed) were injected with 10 mg Gr-1 mAb (A) or alum (B). The mean numbers(+SD) of mature and immature
neutrophils (Fig. S1) in BM, and mean frequencies(+SD) of BrdU
+ cells in the HSC, MPP, and GMP compartments at different intervals after treatment
are shown. Significant differences between C/EBPb
+ and C/EBPb
2/2 mice at corresponding intervals are indicated (day 0, n=12 for C/EBPb
+ mice and
n=7 for C/EBPb
2/2 mice; for all others, n=3–5 mice). **, P#0.01.
doi:10.1371/journal.pone.0019957.g005
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elevated rates of HSPC proliferation (Fig. 2C-E) and a surplus of
immature BM neutrophils (Table S1).
Significantly, increased HSPC proliferation in Mcl-1
2 mice was
only associated with the absence of mature neutrophils; all other
hematopoietic lineages in Mcl-1
2 mice equaled (or were greater
than) that of littermate controls (Table S1). Given that HSPC
proliferation in lymphopenic RAG1
2/2 mice was indistinguish-
able from controls (Fig. 3B), we conclude that the link between
mature BM neutrophils and HSPC proliferation is specific.
Mature neutrophils in BM actively control the pace of granulo-
poiesis by regulating HSPC proliferation.
Following alum or Gr-1 administration, and in Mcl-1
2 mice,
BM neutropenia was associated with lesser or greater increases in
serum G-CSF (Fig. 4A), a cytokine with pleiotropic effects [15,16].
Whereas alum induced sharp, IL-1RI-dependent increases in G-
CSF followed by longer periods of modest G-CSF elevation
(Fig. 4A), the neutropenia induced by Gr-1 mAb or Mcl-1
deficiency was associated only with the modest G-CSF plateau
(Fig. 4A). These distinct kinetics suggest multiple pathways of G-
CSF induction: one driven by inflammation and the second by
neutropenia itself. Whereas alum failed to induce G-CSF in IL-
1RI
2/2 mice (Fig. 1A), neutropenia induced by Gr-1 mAb elicited
G-CSF equally in BL/6 and IL-1RI
2/2 mice (Fig. 4B). We
conclude that alum elicits a rapid increase in G-CSF via IL-1RI to
mobilize BM neutrophil reserves; the sustained plateau of elevated
G-CSF, however, is a consequence of BM neutropenia.
Mice lacking G-CSF-R are neutropenic (Fig. 1D, 4C and [16])
but, in contrast to neutropenic Mcl-1
2 mice, HSPC proliferation
in G-CSF-R
2/2 mice was normal, indicating that HSC and GMP
are insensitive to neutrophil population density in the absence of
G-CSF-R. However, depletion of the residual BM neutrophils in
G-CSF-R
2/2 mice induced a modest, but significant increase in
HSC (but not GMP) proliferation (Fig. 4D). Thus the G-CSF/G-
CSF-R axis is an important mediator of density-dependent
feedback between BM neutrophils and HSPC, but an additional,
G-CSF-R independent feedback signal acts specifically on HSC.
We suggest that BM neutrophils suppress HSPC proliferation
by regulating the availability of G-CSF (and perhaps other
growth factors) to drive HSPC proliferation and differentiation;
the strength of suppression is proportional to the numbers of
mature neutrophils in BM. By mobilizing neutrophils, inflamma-
tion activates this feedback mechanism to increase HSPC
proliferation and neutrophil output. As granulopoiesis acceler-
ates, the number of mature neutrophils in BM increases,
reestablishing a suppressive environment and eventually, the
steady-state equilibrium.
Recent studies concluded that the transcription factors C/EBPa
and C/EBPb operate in GMP as developmental switches for
independent granulopoietic pathways, and that the absence of
reactive neutrophilia in C/EBPb
2/2 mice is the consequence of
defective HSPC proliferation [2]. Our observations, however,
indicate that proliferative responses of C/EBPb
2/2 HSPC to
neutrophil depletion or alum-induced inflammation are normal
(Fig. 5). Instead, in C/EBPb
2/2 mice, the final maturation of
immature neutrophils is impaired during granulopoietic recovery
from Gr-1 treatment (Fig. 5A). Our data suggest that C/EBPa and
C/EBPb operate at distinct stages of granulopoiesis, with C/EBPa
directing the differentiation of CMP to GMP [4], and C/EBPb
acting at terminal neutrophil differentiation. C/EBPb-dependent
processes are necessary for the rapid and efficient generation of
mature neutrophils during emergency granulopoiesis, but are not
rate-limiting in steady-state conditions, as BM neutrophil reserves
are intact in naı ¨ve C/EBPb
2/2 mice (Fig. 5).
We conclude that regulatory feedback is an important source of
signals for the induction of emergency granulopoiesis, a view that
can explain patterns of HSPC proliferation that do not fit standard
granulopoietic models. For example, the lack of HSPC prolifer-
ation in response to vaccinia virus in MyD88
2/2 mice [50] might
be a consequence of impaired neutrophil mobilization. Converse-
ly, pathogens or agents that drain the BM neutrophil reserve will
trigger G-CSF production and increase HSPC proliferation.
Evaluations of growth factors and/or microbial products on
HSPC proliferation and granulopoiesis must consider the effects of
neutrophil mobilization.
Over the last 50 years, various mathematical models have been
developed to describe the changes in granulopoiesis following the
perturbation of neutrophil compartments. Our observations are
remarkably consistent with models that posit the BM neutrophil
compartment as the primary variable for the regulation of
granulopoiesis [10,11]. Our findings, however, imply that the
regulatory effects of BM neutrophil population density extend to
the accelerated granulopoiesis associated with inflammation.
Supporting Information
Figure S1 Flow cytometric definitions of bone marrow
leukocytes. Ter119
2 cells in BM were divided into four
populations (R1–R4) based on side-scatter properties and staining
with Ly-6B mAb. Flow cytometric definitions of lymphocytes
(R1), eosinophils (R2), neutrophils (R3), and monocytes (R4) were
based on the expression Gr-1, Ly-6G, Ly-6C, CD11b, CCR3,
CX3CR1-GFP, TCRb, and B220 and were confirmed by
histological examination of sorted cells. Neutrophil lineage cells
(R3) were subdivided into three populations based on expression
of CD11b and Ly-6G or Gr-1. Cells in R5 expressed the
progenitor markers CD31, CD34 and c-Kit, and exhibited
morphological features of myeloblasts and promyelocytes. Cells in
R6 lost CD31 and CD34 and had low c-Kit staining;
histologically, they were classified as myelocytes and metamyelo-
cytes. Cells in R7 did not express the progenitor markers CD31,
CD34, or c-Kit and exhibited histological features of band and
segmented neutrophils.
(TIF)
Figure S2 Effects of adjuvant immunization and Gr-1
administration on HSPC numbers. BL/6 mice were injected
i.p. with 10 mg Gr-1 (open squares), 100 mg Gr-1 (closed
diamonds), or an alum/antigen mixture (shaded triangles). BM
cells of the hindlimbs were analyzed at different intervals by flow
cytometry, and the numbers of HSC, MPP, and GMP were
determined. The mean(+SD) numbers of cells in the femurs and
tibiae at each interval are shown (day 0, n=19; for others, n=3–
10). In the right panel, the numbers of HSC, MPP, and GMP in
the BM of Mcl-1-sufficient and deficient mice are shown.
(TIF)
Figure S3 Effects of adjuvant immunization and Gr-1
administration on monocytes, eosinophils, B-lineage
cells, and erythroid lineage cells in BM. BL/6 mice were
injected i.p. with 10 mg Gr-1 (open squares), 100 mg Gr-1 (closed
diamonds), or an alum/antigen mixture (shaded triangles). BM
cells of the hindlimbs were analyzed at different intervals by flow
cytometry, and the numbers of monocytes, eosinophils, B-lineage
cells (B220
+), and erythroid lineage cells (Ter119
+) were deter-
mined. The mean(+SD) numbers of cells in the femurs and tibiae
at each interval are shown (day 0, n=19; for others, n=3–10).
Significant differences from naı ¨ve mice are shown for treatment
with 10 mg Gr-1 (*, P#0.05 and **, P#0.01), treatment with
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alum (
#,P #0.05 and
##,P #0.01).
(TIF)
Figure S4 Serum cytokines in inflamed and neutropenic
mice. (A) The concentrations of cytokines in sera of BL/6 mice
immunized with alum (shaded triangles) or treated with 100 mg
Gr-1 mAb (closed diamonds) on days 0, 0.25, 1, 2, and 8 were
determined using a multiplex bead array (n=4–5 mice per data
point). (B) Serum concentrations of cytokines in control Mcl-1
+
mice (open, n=3) and neutropenic Mcl-1
2 mice (shaded, n=7)
are shown. The dotted horizontal line in each graph represents the
lowest concentration of confident detection.
(TIF)
Table S1 Numbers of BM leukocytes (x10
5) in neutro-
phil deficient mice (Mcl-1
2) and control littermates
(Mcl-1
+), and in RAG1
2/2 mice and congenic C57BL/6
mice. The mean numbers(6SD) (x10
5) of each leukocyte type in
the femurs and tibiae of Mcl-1
2 and congenic Mcl-1
+ mice, and in
RAG1
2/2 and congenic BL/6 mice are shown. See Figure S1 for
flowcyometric definitions of B-lineage cells, eosinophils, monocytes,
and neutrophil subpopulations. Statistical significance between the
numbers of cells in knockout mice and congenic controls was
determined by Student’s t-test; (n=5 for Mcl-1
+ mice, n=10 for
Mcl-1
2 mice; n=19 for BL/6 mice; n=4 for RAG1
2/2 mice).
(DOC)
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